L. Greengard

L. Greengard
Name	L. Greengard
Birth date	1925
Death date	2019
Nationality	American
Fields	Neuroscience; Physiology; Biochemistry
Alma mater	Columbia University; Johns Hopkins University
Known for	Synaptic signaling; Phosphorylation; Neurotransmitter receptors
Awards	Nobel Prize in Physiology or Medicine; Louisa Gross Horwitz Prize; Gairdner Foundation International Award

L. Greengard was an American neuroscientist and biochemist whose work elucidated molecular mechanisms of synaptic transmission and intracellular signaling in the nervous system. He established key concepts about protein phosphorylation, second messenger systems, and neurotransmitter receptor regulation that linked classical physiology to molecular neurobiology. Greengard's research influenced fields ranging from pharmacology to psychiatry and informed therapeutic approaches for neurological disorders.

Early life and education

Greengard was born in New York City and completed undergraduate studies at Columbia University before earning a doctoral degree from Johns Hopkins University. During his training he worked with investigators connected to Rockefeller University and the National Institutes of Health environment, interacting with scientists influenced by the traditions of Karl Lashley, Otto Loewi, and laboratory cultures tied to The Rockefeller Institute for Medical Research. His early mentors included figures associated with biochemical and physiological research trajectories that intersected with laboratories at Harvard University, Yale University, and Princeton University.

Career and research

Greengard joined the faculty at Columbia University and later established a laboratory at the Rockefeller University, where he directed investigations into intracellular signaling cascades. His group applied biochemical, electrophysiological, and pharmacological approaches developed in discussions among investigators from Stanford University, Massachusetts Institute of Technology, and University of California, San Francisco. Collaborations and exchanges with researchers from National Institute of Mental Health, Salk Institute, and European centers such as Max Planck Society laboratories fostered cross-disciplinary studies on neuronal protein phosphorylation, cyclic nucleotide pathways, and synaptic vesicle cycles.

Greengard's lab integrated methods from protein chemistry used at Cold Spring Harbor Laboratory with neurophysiological techniques pioneered at Karolinska Institutet and chemical neuroscience insights emerging from groups at University of Cambridge and University of Oxford. He supervised trainees who later took positions at institutions including University of California, Berkeley, Johns Hopkins University School of Medicine, and Columbia Presbyterian Medical Center.

Major contributions and discoveries

Greengard helped define how neurotransmitters modulate neuronal function via protein phosphorylation, revealing roles for kinases and phosphatases in synaptic plasticity. His work connected classical receptor pharmacology associated with Paul Ehrlich-era concepts and modern receptor theory as explored at Scripps Research and Uppsala University. He characterized downstream effects of second messengers such as cyclic AMP linked to studies at University of Chicago and identified molecular correlates of long-term potentiation analogues investigated at Rutgers University and University of California, San Diego.

Notable discoveries included mapping phosphorylation targets of kinases related to the Protein kinase A family, elucidating mechanisms of dopamine and serotonin receptor modulation relevant to research at National Institute on Drug Abuse and Karolinska Institutet, and clarifying presynaptic machinery involved in neurotransmitter release paralleling findings at Albert Einstein College of Medicine and Yale School of Medicine. These contributions bridged insights from Nobel Prize-level traditions and technical advances exemplified at Institut Pasteur and European Molecular Biology Laboratory.

Awards and honors

Greengard received major international recognition, including the Nobel Prize in Physiology or Medicine, the Louisa Gross Horwitz Prize, and the Gairdner Foundation International Award. He was elected to the National Academy of Sciences, the American Academy of Arts and Sciences, and honored by societies such as the Biophysical Society and the Society for Neuroscience. Universities including Harvard University, Columbia University, and Yale University awarded him honorary degrees or chairs in recognition of his impact on neuroscience and biochemistry.

Selected publications

- Greengard L., seminal articles on synaptic phosphoproteins published in leading journals alongside contemporaries from Science and Nature. - Reviews synthesizing signaling pathways and receptor regulation influenced by work from Neuron and Journal of Neuroscience contributors. - Monographs and edited volumes produced with editors from Cold Spring Harbor Laboratory Press and collaborators linked to Annual Review of Neuroscience.

Personal life and legacy

Greengard maintained connections with cultural and scientific institutions in New York City, supported local medical centers including Mount Sinai Health System and engaged with philanthropic organizations similar to Howard Hughes Medical Institute donors. His trainees and collaborators established research programs at centers such as Massachusetts General Hospital, Memorial Sloan Kettering Cancer Center, and international universities including University of Toronto and ETH Zurich, extending his scientific lineage. The paradigms he developed continue to inform drug discovery in settings at Pfizer-affiliated research groups, biotech startups spun out of Columbia University technology transfer, and translational neuroscience initiatives worldwide.

Category:American neuroscientists